Low Dose Tamoxifen for Mammographic Density Reduction

PHASE2CompletedINTERVENTIONAL

Enrollment

1,440

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

October 31, 2019

Study Completion Date

December 31, 2019

Conditions

Risk ReductionMammographic Density Reduction

Interventions

DRUG

Tamoxifen Oral Tablet

Randomised dose of tamoxifen 1 pill/day for 180 days

DRUG

Placebo Oral Tablet

Randomised dose of tamoxifen 1 pill/day for 180 days

All Listed Sponsors

lead

Per Hall

OTHER

NCT03346200 - Low Dose Tamoxifen for Mammographic Density Reduction | Biotech Hunter | Biotech Hunter